EKOS Overview

  • Founded
  • 1996
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 99
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $180M
Latest Deal Amount
  • Investors
  • 1

EKOS General Information

Description

Developer of clinical application of microsonic technologies for the treatment of vascular thrombosis. The company's products include EkoSonic endovascular system with MACH4e for the controlled and selective infusion of physician-specified fluids.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Parent Company
Primary Office
  • 11911 North Creek Parkway South
  • Suite 101
  • Bothell, WA 98011
  • United States
+1 (425) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EKOS Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Merger/Acquisition 08-Jul-2013 $180M 00000 00000 Completed Generating Revenue
10. Later Stage VC (Series D) 20-Dec-2010 00.00 00000 00000 Completed Generating Revenue
9. Grant 07-Jun-2010 00.00 000.00 Completed Generating Revenue
8. Later Stage VC (Series D) 07-Jan-2009 000.00 000.00 00000 Completed Generating Revenue
7. Later Stage VC (Series D) 25-Mar-2008 000 000.00 000.00 Completed Generating Revenue
6. Later Stage VC (Series C) 31-Dec-2007 00.000 0000 000.00 Completed Generating Revenue
5. Mezzanine 25-May-2007 00.000 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 31-Mar-2006 0000 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series B1) 18-Feb-2005 $18M $32.3M 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 11-Jun-1998 $10M $14.3M 000.00 Completed Generating Revenue
To view EKOS’s complete valuation and funding history, request access »

EKOS Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series C 000,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B1 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series Z 00,000,000 00.000000 00.00 00.0 00.0 00
Series A3 prime 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A3 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A2 prime 00,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A2 1,631,997 $0.001000 $0.15 $1.9 $1.9 1x $0.33 2.76%
Series A1 40,043,846 $0.001000 $0.03 $0.39 $0.39 1x $0.33 13.84%
To view EKOS’s complete cap table history, request access »

EKOS Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of clinical application of microsonic technologies for the treatment of vascular thrombosis. The company's pro
Surgical Devices
Bothell, WA
99 As of 2010
00000
0000 0000-00-00
000000&0 00000

00000000

m dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore
00000000 0000000
New York, NY
000 As of 0000
000000 - 000

00000 00

ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse c
00000000 0000000
Irvine, CA
000 As of 0000
00000
0000 0000-00-00
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EKOS Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Angiodynamics Corporation New York, NY 000 000000 - 000
00000 0000000 Formerly VC-backed Irvine, CA 000 00000 00000000 00000
00000000 Formerly VC-backed San Diego, CA 0000 00000 000000 - 000 00000
0000 0000000 Corporation Bloomington, IN 00000
000000 00000000 Venture Capital-Backed Bedford, MA 00 000.00 00000000000 000.00
You’re viewing 5 of 24 competitors. Get the full list »

EKOS Executive Team (11)

Name Title Board Seat Contact Info
Douglas Hansmann Co-Founder & Chief Operating Officer
Curtis Genstler Director, Integration
Lori Melkerson Vice President, Operations
You’re viewing 3 of 11 executive team members. Get the full list »

EKOS Board Members (7)

Name Representing Role Since
Richard Robb Self Board Member 000 0000
You’re viewing 1 of 7 board members. Get the full list »

EKOS Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EKOS Former Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ARCH Venture Partners Venture Capital Minority 000 0000 000000 0
Ascension Ventures Corporate Venture Capital Minority 000 0000 000000 0
Bank of America Merrill Lynch Investment Bank Minority 000 0000 000000 0
Bessemer Venture Partners Venture Capital Minority 000 0000 000000 0
CID Equity Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 20 investors. Get the full list »